|
Principle of the method
Protein present in CSF is measured by precipitating the
proteins with 3g% sulphosalicylic acid and
comparing the absorbance of the turbidity at 640 nm with that of protein standards.
Reagents
All chemicals must be Analar
grade
Sodium
chloride diluent
Dissolve 9g of sodium chloride and 0.5 g of sodium azide together in a final volume of one litre of distilled water in a volumetric flask. Store the
solution in an amber coloured bottle. Stable for
one year at 25-350C.
Sulphosalicylic
acid 3g/dl
Dissolve 30 g sulphosalicylic
acid in a final volume of one litre distilled
water. Store in an amber coloured bottle at 25-350C.
Stable for 6 months.
Standards
Refer Total Protein (page 40, (c) Standard for the
preparation of protein standard from pooled serum. Note that there is always
a risk of infection from pooled serum.
After determining the concentration of the protein
standard, dilute this to several levels as described below.
For example, if the total protein value of the pooled
serum is6.7g/dl, then the volume of pooled serum to be diluted to
100ml to get a protein concentration of 20 mg/dl is found out using the
dilution formula.
IV x IC = FV x FC
IV = Initial Volume of pooled serum.
IC= Initial Concentration of total protein
(mg/dl).
FV = Final Volume.
FC = Final Concentration.
IV x 6700 = 100 x 20
IV
= 100 x 20 20
----------- = ----- = 0.3 ml
6700 67
i.e. Dilute 0.3 ml of the pooled
serum to 100ml with 0.9 g/dl sodium chloride containing 0.1g/dl sodium azide. Similarly, 40, 80 and 120 mg/dl standards are
prepared by diluting 0.6, 1.2 and 1.8 ml of the pooled serum each to 100 ml
with the diluent. The standards are stable at 2-80C
for one month.
The following table summarizes the preparation of
diluted standards.
Concentration of protein in pooled serum is taken
as 6.7g/dl.
|
Standard
|
Pooled
serum (ml)
|
Final
diluted
volume (ml)
|
Concentration
of
Standard (mg/dl)
|
|
S1
|
0.3
|
100
|
20
|
|
S2
|
0.6
|
100
|
40
|
|
S3
|
1.2
|
100
|
80
|
|
S4
|
1.8
|
100
|
120
|
Equipment, glassware and other accessories
Refer to Section A (2), Introduction to SOP.
Procedure
The protocol of the procedure is described below.
Pipette the following into appropriately labelled 13 x 100 mm tubes
|
|
Blank
|
S1
|
S2
|
S3
|
S4
|
Test
|
QC
|
|
Protein standard (ml)
|
-
|
1.0
|
1.0
|
1.0
|
1.0
|
-
|
-
|
|
Test sample (ml)
|
-
|
-
|
-
|
-
|
-
|
1.0
|
-
|
|
QC serum(1:100) (ml)
|
-
|
-
|
-
|
-
|
-
|
-
|
1.0
|
|
Sodium chloride (ml)
|
1.0
|
-
|
-
|
-
|
-
|
-
|
-
|
|
Sulphosalicylic acid (ml)
|
3.0
|
3.0
|
3.0
|
3.0
|
3.0
|
3.0
|
3.0
|
Mix all tubes well. Leave at 25-350C for 5
minutes. Set the spectrophotometer /filter photometer to zero using blank at
640 nm/ red filter and measure the absorbance of standards, test and QC.
Calculation and calibration graph
Since standards and test/ QC procedures are identical,
the absorbance values of standards are plotted against their respective
concentrations. The calibration curve should be linear up to 120 mg/dl with a
lower limit of 10 mg/dl.
Plot the absorbance values of test on the calibration
graph and read off protein concentrations in patients’ CSF. As 1: 100 diluted
QC serum 's analysed, read
off protein concentration in QC on the calibration graph and multiply the
value by I 00 to get the correct protein value in QC serum.
Once linearity is proved, it is not necessary to prepare
the standard graph every time when patients’ samples are analysed.
It will be adequate if only standard S4 is taken every time and patients'
results are calculated using the formula.
Test
absorbance
----------------------------- x 120...... mg/dl.
Standard absorbance

Analytical reliabilities
Refer to pages 7-9 of section 1 (General
Introduction) on the use of internal QC and interpretation of daily QC
data (for releasing patients’ results).
Include one internal QC every time a patient specimen is
measured, irrespective of the number of samples in a batch. However, even if
only a single QC sample is analysed in a day, this
value can be pooled with the preceding 10 or 20 values obtained in the previous
days and between-day precisioncan be calculated and
expressed as %CV. Ensure that this is well within the acceptable limit, i.e, 8%.
At least once a week analyse
another QC serum from either a low QC or high QC pool.
"Assayed" QC sera with stated values (ranges)
are available from several commercial sources, viz. Boehringer
Mannheim, BioRad & Randox.
If a laboratory uses QC sera rom
a commercial source, it is important that the company certifies that their QC
materials are traceable to international reference materials.
Hazardous materials
This procedure uses sodium azide and sulphosalicylic acid.
Do not swallow, and avoid contact with skin and mucous membranes.
Reference range and clinical interpretation
CSF protein - 15-45 mg/dl
Normally the protein present inCSF is entirely
albumin, but in many disease states CSF contains a mixture of albumin and
globulins. Increase in proteins up to 400 mg/dl is observed in meningitis and
up to several grams in spinal tumour. In
inflammatory lesion, increase in protein is associated with increase in
cells. A marked increase is also observed in paralysis and in disseminated
sclerosis.
Abnormally increased total CSF protein may be found in
conditions where there is an increased permeability of the capillary endothelical barrier through which ultrafiltration
occurs. Examples of such conditions include; bacterial, viral and fungal
meningitis, traumatic tap, multiple sclerosis, obstruction, neoplasm and
cerebral infarction.
Limitations
Any CSF protein value > 120 mg/dl should be diluted
with 0.9% saline either 1:2 or 1:3 and re-assayed, and the value obtained is
multiplied by the appropriate dilution factor to get the correct value. The
presence of blood and pus increases CSF total protein. The report to the
requesting physician should include the appearance of CSF before and after
centrifugation.
Reference
1. Varley’s Practical Clinical Biochemistry. 6th edition, published by Heinemann Medical Books, London
(1988) page 447-448.
|